Cargando…
In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors
Magnolia grandiflora L. (Magnoliaceae) is a plant of considerable medicinal significance; its flowers and seeds have been used in various traditional remedies. Radioligand binding assays of n-hexane seeds extract showed displacement of radioligand for cannabinoid (CB1 and CB2) and opioid δ (delta),...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920749/ https://www.ncbi.nlm.nih.gov/pubmed/36770918 http://dx.doi.org/10.3390/molecules28031253 |
_version_ | 1784887146031611904 |
---|---|
author | Pandey, Pankaj Kumarihamy, Mallika Chaturvedi, Krishna Ibrahim, Mohamed A. M. Lambert, Janet A. Godfrey, Murrell Doerksen, Robert J. Muhammad, Ilias |
author_facet | Pandey, Pankaj Kumarihamy, Mallika Chaturvedi, Krishna Ibrahim, Mohamed A. M. Lambert, Janet A. Godfrey, Murrell Doerksen, Robert J. Muhammad, Ilias |
author_sort | Pandey, Pankaj |
collection | PubMed |
description | Magnolia grandiflora L. (Magnoliaceae) is a plant of considerable medicinal significance; its flowers and seeds have been used in various traditional remedies. Radioligand binding assays of n-hexane seeds extract showed displacement of radioligand for cannabinoid (CB1 and CB2) and opioid δ (delta), κ (kappa), and µ (mu) receptors. Bioactivity-guided fractionation afforded 4-O-methylhonokiol (1), magnolol (2), and honokiol (3), which showed higher binding to cannabinoid rather than opioid receptors in radioligand binding assays. Compounds 1–3, together with the dihydro analog of 2 (4), displayed selective affinity towards CB2R (K(i) values of 0.29, 1.4, 1.94, and 0.99 μM, respectively), compared to CB1R (K(i) 3.85, 17.82, 14.55, and 19.08 μM, respectively). An equal mixture of 2 and 3 (1:1 ratio) showed additive displacement activity towards the tested receptors compared to either 2 or 3 alone, which in turn provides an explanation for the strong displacement activity of the n-hexane extract. Due to the unavailability of an NMR or X-ray crystal structure of bound neolignans with the CB1 and CB2 receptors, a docking study was performed to predict ligand–protein interactions at a molecular level and to delineate structure-activity relationships (SAR) of the neolignan analogs with the CB1 and CB2 receptors. The putative binding modes of neolignans 1–3 and previously reported related analogs (4, 4a, 5, 5a, 6, 6a, and 6b) into the active site of the CB1 and CB2 receptors were assessed for the first time via molecular docking and binding free-energy (∆G) calculations. The docking and ∆G results revealed the importance of a hydroxyl moiety in the molecules that forms strong H-bonding with Ser383 and Ser285 within CB1R and CB2R, respectively. The impact of a shift from a hydroxyl to the methoxy group on experimental binding affinity to CB1R versus CB2R was explained through ∆G data and the orientation of the alkyl chain within the CB1R. This comprehensive SAR, influenced by the computational study and the observed in vitro displacement binding affinities, has indicated the potential of magnolia neolignans for developing new CB agonists for potential use as analgesics, anti-inflammatory agents, or anxiolytics. |
format | Online Article Text |
id | pubmed-9920749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99207492023-02-12 In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors Pandey, Pankaj Kumarihamy, Mallika Chaturvedi, Krishna Ibrahim, Mohamed A. M. Lambert, Janet A. Godfrey, Murrell Doerksen, Robert J. Muhammad, Ilias Molecules Article Magnolia grandiflora L. (Magnoliaceae) is a plant of considerable medicinal significance; its flowers and seeds have been used in various traditional remedies. Radioligand binding assays of n-hexane seeds extract showed displacement of radioligand for cannabinoid (CB1 and CB2) and opioid δ (delta), κ (kappa), and µ (mu) receptors. Bioactivity-guided fractionation afforded 4-O-methylhonokiol (1), magnolol (2), and honokiol (3), which showed higher binding to cannabinoid rather than opioid receptors in radioligand binding assays. Compounds 1–3, together with the dihydro analog of 2 (4), displayed selective affinity towards CB2R (K(i) values of 0.29, 1.4, 1.94, and 0.99 μM, respectively), compared to CB1R (K(i) 3.85, 17.82, 14.55, and 19.08 μM, respectively). An equal mixture of 2 and 3 (1:1 ratio) showed additive displacement activity towards the tested receptors compared to either 2 or 3 alone, which in turn provides an explanation for the strong displacement activity of the n-hexane extract. Due to the unavailability of an NMR or X-ray crystal structure of bound neolignans with the CB1 and CB2 receptors, a docking study was performed to predict ligand–protein interactions at a molecular level and to delineate structure-activity relationships (SAR) of the neolignan analogs with the CB1 and CB2 receptors. The putative binding modes of neolignans 1–3 and previously reported related analogs (4, 4a, 5, 5a, 6, 6a, and 6b) into the active site of the CB1 and CB2 receptors were assessed for the first time via molecular docking and binding free-energy (∆G) calculations. The docking and ∆G results revealed the importance of a hydroxyl moiety in the molecules that forms strong H-bonding with Ser383 and Ser285 within CB1R and CB2R, respectively. The impact of a shift from a hydroxyl to the methoxy group on experimental binding affinity to CB1R versus CB2R was explained through ∆G data and the orientation of the alkyl chain within the CB1R. This comprehensive SAR, influenced by the computational study and the observed in vitro displacement binding affinities, has indicated the potential of magnolia neolignans for developing new CB agonists for potential use as analgesics, anti-inflammatory agents, or anxiolytics. MDPI 2023-01-27 /pmc/articles/PMC9920749/ /pubmed/36770918 http://dx.doi.org/10.3390/molecules28031253 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pandey, Pankaj Kumarihamy, Mallika Chaturvedi, Krishna Ibrahim, Mohamed A. M. Lambert, Janet A. Godfrey, Murrell Doerksen, Robert J. Muhammad, Ilias In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors |
title | In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors |
title_full | In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors |
title_fullStr | In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors |
title_full_unstemmed | In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors |
title_short | In Vitro and In Silico Studies of Neolignans from Magnolia grandiflora L. Seeds against Human Cannabinoids and Opioid Receptors |
title_sort | in vitro and in silico studies of neolignans from magnolia grandiflora l. seeds against human cannabinoids and opioid receptors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9920749/ https://www.ncbi.nlm.nih.gov/pubmed/36770918 http://dx.doi.org/10.3390/molecules28031253 |
work_keys_str_mv | AT pandeypankaj invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors AT kumarihamymallika invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors AT chaturvedikrishna invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors AT ibrahimmohamedam invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors AT lambertjaneta invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors AT godfreymurrell invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors AT doerksenrobertj invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors AT muhammadilias invitroandinsilicostudiesofneolignansfrommagnoliagrandifloralseedsagainsthumancannabinoidsandopioidreceptors |